Moore Capital Management »

BioCryst Pharmaceuticals shares owned by Moore Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.5M 848k 10.00
2022-12-31 $746k 65k 11.48